Literature DB >> 16308265

Characterization of the biochemical effects of 1-nitronaphthalene in rats using global metabolic profiling by NMR spectroscopy and pattern recognition.

J Azmi1, J Connelly, E Holmes, J K Nicholson, R F Shore, J L Griffin.   

Abstract

Metabolic fingerprints, in the form of patterns of high-concentration endogenous metabolites, of 1-nitronaphthalene (NN)-induced lung toxicity have been elucidated in bronchoalveolar lavage fluid (BALF), urine, blood plasma, and intact lung and liver tissue using NMR spectroscopy-based metabolic profiling. A single dose of NN (75 mg kg(-1)) was administered orally to Sprague-Dawley rats. BALF and lung tissue were obtained 24 h after dosing from these animals and matched control rats post-mortem. High-resolution (1)H-NMR spectroscopy of BALF samples indicated that NN caused increases in concentrations of choline, amino acids (leucine, isoleucine and alanine) and lactate together with decreased concentrations of succinate, citrate, creatine, creatinine and glucose. In addition, the intact lung weights were higher in the NN-treated group (p<0.01), consistent with pulmonary oedema. The NMR-detected perturbations indicated that NN induces a perturbation in energy metabolism in both lung and liver tissue, as well as surfactant production and osmolyte levels in the lungs. As well as reporting the first NMR spectroscopic combined examination of BALF and intact lung, this study indicates that such holistic approaches to investigating mechanisms of lung toxicity may be of value in evaluating disease progression or the effects of therapeutic intervention in pulmonary conditions such as surfactant disorders or asthma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16308265     DOI: 10.1080/13547500500309259

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  6 in total

1.  Metabolomics reveals altered metabolic pathways in experimental asthma.

Authors:  Wanxing Eugene Ho; Yong-Jiang Xu; Fengguo Xu; Chang Cheng; Hong Yong Peh; Steven R Tannenbaum; W S Fred Wong; Choon Nam Ong
Journal:  Am J Respir Cell Mol Biol       Date:  2012-11-09       Impact factor: 6.914

Review 2.  Clinical applications of metabolomics in oncology: a review.

Authors:  Jennifer L Spratlin; Natalie J Serkova; S Gail Eckhardt
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

3.  Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM).

Authors:  Teresa W M Fan; Andrew N Lane; Richard M Higashi; Mohamed A Farag; Hong Gao; Michael Bousamra; Donald M Miller
Journal:  Mol Cancer       Date:  2009-06-26       Impact factor: 27.401

4.  Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients.

Authors:  Justyna E Wolak; Charles R Esther; Thomas M O'Connell
Journal:  Biomarkers       Date:  2009-02       Impact factor: 2.658

5.  Metabolomic Analysis of Platelets of Patients With Aspirin Non-Response.

Authors:  Jiun-Yang Chiang; Sheng-Han Lee; Yen-Ching Chen; Cho-Kai Wu; Jing-Yuan Chuang; Shyh-Chyi Lo; Huei-Ming Yeh; Shih-Fan Sherri Yeh; Cheng-An Hsu; Bin-Bin Lin; Pi-Chu Chang; Chih-Hsin Chang; Hao-Jan Liang; Fu-Tien Chiang; Ching-Yu Lin; Jyh-Ming Jimmy Juang
Journal:  Front Pharmacol       Date:  2019-10-10       Impact factor: 5.810

6.  Metabonomics study of the therapeutic mechanism of Gynostemma pentaphyllum and atorvastatin for hyperlipidemia in rats.

Authors:  Miao Wang; Fei Wang; Yinan Wang; Xiaonan Ma; Min Zhao; Chunjie Zhao
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.